Bafna Pharmaceuticals informs about PCS certificate

11 Apr 2022 Evaluate
Bafna Pharmaceuticals has informed that it enclosed certificate from Practicing Company Secretary under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the half year ended 31st March 2022.

The above information is a part of company’s filings submitted to BSE.

Bafna Pharma Share Price

99.75 0.00 (0.00%)
13-May-2024 15:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.20
Dr. Reddys Lab 5872.35
Cipla 1405.95
Zydus Lifesciences 997.45
Lupin 1638.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.